Comprehensive Review on the Formulation Methods and Evaluation Parameters for Nanosuspension Formulation
Marabathuni V Jhansi Priya, Chennu M M Prasada Rao
Abstract:
The preparation methods for nanosuspension formulation include both top-down methods like wet milling, dry milling, high-pressure homogenization, and co-grinding, and bottom-up methods. These methods help in enhancing the solubility of poorly water-soluble drugs, providing a promising alternative to traditional formulations. Additionally, the evaluation of nanosuspensions involves assessing various formulation parameters to determine factors such as enhanced dissolution and bioavailability. By considering components, preparation methods, process parameters, and administration routes, researchers aim to optimize nanosuspension formulations for different applications. These strategies help in developing effective nanosuspensions for various administration routes.
Keywords: Nanosuspensions, Top-down Methods, Bioavailability, Evaluation Parameters.
References:
[1] Tadros T. Encyclopedia of Colloid and Interface Science. Berlin, Heidelberg: Springer Berlin Heidelberg; 2013. 748–781 p.
[2] Shah MR, Imran M, Ullah S. Nanosuspensions. In: Lipid-Based Nanocarriers for Drug Delivery and Diagnosis. Elsevier; 2017. p. 139–172.
[3] Goel S, Sachdeva M, Agarwal V. Nanosuspension Technology: Recent Patents on Drug Delivery and their Characterizations. Recent Pat Drug Deliv Formul. 2019 Aug 29;13(2):91–104.
[4] Sutradhar KB, Khatun S, Luna IP. Increasing Possibilities of Nanosuspension. J Nanotechnol. 2013;2013:1–12.
[5] Velmula M, Pavuluri P, Rajashekar S. Nanosuspension Technology For Poorly Soluble Drugs – A Review. World J Pharm Pharm Sci. 4(07):1612–1625.
[6] Prabhakar C, Krishna KB. A Review on Nanosuspensions In Drug Delivery. Int J Pharma Bio Sci. 2011 Mar;2(1):549–558.
[7] Muller RH, Jacobs C, Kayser O. Nanosuspensions as particulate drug formulations in therapy Rationale for development and what we can expect for the future. Adv Drug Deliv Rev. 2001;47:3– 19.
[8] Rabinow BE. Nanosuspensions in drug delivery. Nat Rev Drug Discov. 2004 Sep;3(9):785–796.
[9] Liu P, Rong X, Laru J, van Veen B, Kiesvaara J, Hirvonen J, et al. Nanosuspensions of poorly soluble drugs: preparation and development by wet milling. Int J Pharm. 2011 Jun 15;411(1–2):215–222.
[10] Ibrahim HM, Ismail HR, Lila AEA. Formulation and optimization of ocular poly- D, L-lactic acid nano drug delivery system of amphotericin-B using box behnken design. Int J Pharm Pharm Sci. 2012 Jan 1;4(2):342–349.
[11] Nimmi R, Shripathy D, Shabaraya AR. Pharmaceutical Nanosuspension: An Overview. World J Pharm Pharm Sci. 2021 May 23;10(6):921–936.
[12] Nagaraju P, Krishnachaithanya K, Srinivas VDN, Padma SVN. Nanosuspensions: A Promising Drug Delivery Systems. Int J Pharm Sci Nanotechnol. 2010 Feb 28;2(4):679–684.
[13] Koteshwara KB, Reddy MS, Naha A, Nampoothiri M. Nanosuspensions: A Novel Drug Delivery Approach. Int J Res Ayurveda Pharm. 2011;2(1):162–165.
[14] Mudgil M, Gupta N, Nagpal M, Pawar P. Nanotechnology: A New Approach For Ocular Drug Delivery System. Int J Pharm Pharm Sci. 2012 Feb 11;4(2):105–112.
[15] Chaurasia T, Singh D, N, Srivastava D. A Review on Nanosuspensionspromising Drug Delivery Strategy. J Curr Pharma Res. 2012 Nov 15;3(1):764–776.
[16] Van Eerdenbrugh B, Van den Mooter G, Augustijns P. Top-down production of drug nanocrystals: Nanosuspension stabilization, miniaturization and transformation into solid products. Int J Pharm. 2008 Nov;364(1):64–75.
[17] De Waard H, Hinrichs W, Frijlink H. A novel bottom-up process to produce drug nanocrystals: Controlled crystallization during freeze-drying. J Control Release Off J Control Release Soc. 2008 Jul 1;128(2):179–183.
[18] Moschwitzer J, Achleitner G, Pomper H, Muller RH. Development of an intravenously injectable chemically stable aqueous omeprazole formulation using nanosuspension technology. Eur J Pharm Biopharm Off J Arbeitsgemeinschaft Pharm Verfahrenstechnik EV. 2004 Nov;58(3):615–619.
[19] Muller R, Jacobs C, Kayer O. Nanosuspensions for the formulation of poorly soluble drugs. Pharmaceutical emulsion and suspension. NewYork: Marcel Dekker; 2000. 383–407 p.
[20] Keck CM, Muller RH. Drug nanocrystals of poorly soluble drugs produced by high pressure homogenisation. Eur J Pharm Biopharm. 2006 Jan;62(1):3–16.
[21] Vaghela A. Nanosuspension Technology. Int J Univers Pharm Life Sci. 2012;2(2):306– 317.
[22] Lakshmi P, Kumar GA. Nano-Suspension Technology: A Review. Int J Pharm Pharm Sci. 2010 Sep 18;2:35–40.
[23] Liversidge GG, Cundy KC, Bishop JF, Czekai DA. Surface modified drug nanoparticles. CA2059432C, 2003.
[24] Wongmekiat A, Tozuka Y, Oguchi T, Yamamoto K. Formation of fine drug particles by cogrinding with cyclodextrins. I. The use of beta-cyclodextrin anhydrate and hydrate. Pharm Res. 2002 Dec;19(12):1867–1872.
[25] Remington JP, Gennaro AR. Remington’s pharmaceutical sciences. 18th ed. Easton, Pa.: Mack Pub. Co.; 1990. 589–602 p.
[26] Bodmeier R, McGinity JW. Solvent selection in the preparation of poly(dl-lactide) microspheres prepared by the solvent evaporation method. Int J Pharm. 1988 Apr;43(1–2):179–186.
[27] Sah H. Microencapsulation techniques using ethyl acetate as a dispersed solvent: effects of its extraction rate on the characteristics of PLGA microspheres. J Controlled Release. 1997 Sep;47(3):233– 245.
[28] Kamble VA, Jagdale DM, Kadam VJ. Nanosuspension a novel drug delivery system. Int J Pharm Biosci. 2010;1:352– 360.
[29] Kipp JE, Wong JCT, Doty MJ, Rebbeck CL. Microprecipitation method for preparing submicron suspensions. US7037528B2, 2006.
[30] Swarbrick J, Boylan JC. Encyclopedia of Pharmaceutical Technology. Vol. 20. New York: Marcel Dekker; 2001.
[31] Trotta M, Gallarate M, Carlotti ME, Morel S. Preparation of griseofulvin nanoparticles from water-dilutable microemulsions. Int J Pharm. 2003 Mar 26;254(2):235–242.
[32] Arunkumar N, Deecaraman M, Rani C. Nanosuspension technology and its applications in drug delivery. Asian J Pharm. 2009;3(3):168–173.
[33] Thodeti S, bandikatla H, Kumar Y. Synthesis and Characterization of ZnO Nanostructures By Oxidation Technique. Int J Adv Res Sci Eng. 2017 Nov;6(11):539– 544.
[34] Liversidge GG, Cundy KC. Particle size reduction for improvement of oral bioavailability of hydrophobic drugs: I. Absolute oral bioavailability of nanocrystalline danazol in beagle dogs. Int J Pharm. 1995 Oct 17;125(1):91–97.
[35] Otsuka H, Nagasaki Y, Kataoka K. PEGylated nanoparticles for biological and pharmaceutical applications. Adv Drug Deliv Rev. 2003 Feb 24;55(3):403–419.
[36] Hunter RJ. Foundations of Colloid Science. Second Edition. Oxford, New York: Oxford University Press; 2000. 820 p.
[37] Paun J, Tank HM. Nanosuspension: An Emerging Trend for Bioavailability Enhancement of Poorly Soluble Drugs. Asian J Pharm Technol. 2012;2:157–168.
[38] Wu L, Zhang J, Watanabe W. Physical and chemical stability of drug nanoparticles. Adv Drug Deliv Rev. 2011 May 30;63(6):456–469.
[39] Sutradhar, Kumar & Khatun, S. & Luna, Irin. (2013). Increasing Possibilities of Nanosuspension. Journal of Nanotechnology. 2013. 10.1155/2013/346581.
[40] Katmıs A, Fide S, Karaismailoglu S, Derman S. Synthesis and characterization methods of polymeric nanoparticles. Characterization and Application of Nanomaterials. 2019 Aug 14;2(2):60-6.